Sign In
Buy SYK
$295.00
+1.70 (+0.580%)
At Close: Jun 03, 2026
Stryker's Strategic Moves Impress Analysts, Spine Implant Sale and NARI Deal Set to Drive Future Growth
01:48pm, Wednesday, 29'th Jan 2025
Wall Street analysts rerated Stryker Corp SYK Wednesday after the company's fourth-quarter print.
Stryker's Strategic Moves Impress Analysts, Spine Implant Sale and NARI Deal Set to Drive Future Growth
01:48pm, Wednesday, 29'th Jan 2025
Wall Street analysts rerated Stryker Corp SYK Wednesday after the company's fourth-quarter print.
Stryker Stock Falls on Deal to Sell Its U.S. Spinal Implants Business
12:36pm, Wednesday, 29'th Jan 2025
SYK announces agreement to sell its U.S. spinal implants business to Viscogliosi Brothers, LLC.
SYK Stock Down Despite Q4 Earnings Beat and Spine Biz Divestment Plans
12:11pm, Wednesday, 29'th Jan 2025
SYK's fourth-quarter results reflect strong segmental performance, along with a rise in operating margin.
Stryker Corporation (SYK) Q4 2024 Earnings Conference Call Transcript
09:34pm, Tuesday, 28'th Jan 2025
Stryker Corporation (NYSE:SYK ) Q4 2024 Earnings Conference Call January 28, 2025 4:30 PM ET Company Participants Kevin Lobo - Chairman, CEO & President Andy Pierce - Group President of MedSurg & Neur
Stryker (SYK) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
07:01pm, Tuesday, 28'th Jan 2025
Although the revenue and EPS for Stryker (SYK) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Stree
Stryker (SYK) Q4 Earnings and Revenues Surpass Estimates
06:15pm, Tuesday, 28'th Jan 2025
Stryker (SYK) came out with quarterly earnings of $4.01 per share, beating the Zacks Consensus Estimate of $3.87 per share. This compares to earnings of $3.46 per share a year ago.
Stryker forecasts 2025 profit above estimates on robust demand for surgical devices
05:33pm, Tuesday, 28'th Jan 2025
Stryker beat Wall Street estimates for fourth-quarter profit and forecast 2025 earnings largely above expectations on Tuesday, fueled by strong demand for its medical and surgical devices.
Overlooked Stock: SYK
04:45pm, Tuesday, 28'th Jan 2025
Stryker Corp. (SYK) ticked higher after hours after the medical tech company posted an earnings beat. George Tsilis turned to how a rally from this mostly unseen stock reflects the healthcare industry
Stryker reports 2024 operating results and 2025 outlook
04:05pm, Tuesday, 28'th Jan 2025
Portage, Michigan, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the fourth quarter and full year of 2024:
Stryker announces the retirement of Glenn S. Boehnlein and the promotion of Preston Wells to Vice President, Chief Financial Officer
04:05pm, Tuesday, 28'th Jan 2025
Portage, Michigan, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK) announced today that Glenn S. Boehnlein will retire from his role as Vice President, Chief Financial Officer. Boehnlein's decis
Portage, Michigan, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK), a global leader in medical technologies, announced today a definitive agreement to sell its U.S. spinal implants business to Vi
Strong Segmental Performance to Drive Stryker's Q4 Earnings?
01:35pm, Monday, 27'th Jan 2025
SYK's fourth-quarter 2024 results are expected to reflect strong segmental performance. However, rising costs are likely to have continued to hurt margins.
Stryker: A Cool Name For An Awesome Company, But Is It A Buy Ahead Of Earnings?
12:49pm, Monday, 27'th Jan 2025
Stryker Corporation is a high-quality, innovative medical device company with a strong history of revenue, earnings, and FCF growth, driven by R&D and M&A strategies. Shares are currently expensive wi
PAHC vs. SYK: Which Stock Should Value Investors Buy Now?
12:41pm, Friday, 24'th Jan 2025
Investors interested in stocks from the Medical - Products sector have probably already heard of Phibro Animal Health (PAHC) and Stryker (SYK). But which of these two stocks presents investors with th
